{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:16:44Z","timestamp":1793114204170,"version":"4.5.0"},"update-to":[{"DOI":"10.1016\/j.ijbiomac.2023.125863","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000}}],"reference-count":211,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100020481","name":"Shahid Beheshti University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ijbiomac.2023.125863","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T20:27:23Z","timestamp":1689625643000},"page":"125863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["RETRACTED: microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance"],"prefix":"10.1016","volume":"250","author":[{"given":"Mehdi","family":"Fattahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Shahrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Saadatpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delsuz","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Beyglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Delavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Amrolahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Bagheri-Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effat","family":"Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Majidpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohsen","family":"Aghaei-Zarch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Falahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binh Nguyen","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"39","key":"10.1016\/j.ijbiomac.2023.125863_bb0005","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1038\/onc.2014.456","article-title":"Junk DNA and the long non-coding RNA twist in cancer genetics","volume":"34","author":"Ling","year":"2015","journal-title":"Oncogene."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.853180","article-title":"The emerging roles of the \u03b2-secretase BACE1 and the long non-coding RNA BACE1-AS in human diseases: a focus on neurodegenerative diseases and cancer","volume":"14","author":"Sayad","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymeth.2020.06.022","article-title":"Modern epigenetics methods in biological research","volume":"187","author":"Li","year":"2021","journal-title":"Methods."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153639","article-title":"CiRS-7\/CDR1as; an oncogenic circular RNA as a potential cancer biomarker","volume":"227","author":"Rahmati","year":"2021","journal-title":"Pathol. Res. Pract."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125863_bb0025","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3390\/ijms17101712","article-title":"MicroRNA in control of gene expression: an overview of nuclear functions","volume":"17","author":"Catalanotto","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0030","article-title":"Oncogenic roles of small nucleolar RNA host gene 7 (SNHG7) long noncoding RNA in human cancers and potentials","volume":"9","author":"Najafi","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/ncrna5010017","article-title":"Long non-coding RNAs in the regulation of gene expression: physiology and disease","volume":"5","author":"Fernandes","year":"2019","journal-title":"Non-Coding RNA"},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153720","article-title":"Circular RNAs in renal cell carcinoma: functions in tumorigenesis and diagnostic and prognostic potentials","volume":"229","author":"Sayad","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105920","article-title":"Long noncoding RNA p21 enhances autophagy to alleviate endothelial progenitor cells damage and promote endothelial repair in hypertension through SESN2\/AMPK\/TSC2 pathway","volume":"173","author":"Li","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0050","first-page":"14","article-title":"The emerging roles of the \u03b2-secretase BACE1 and the long non-coding RNA BACE1-AS in human diseases: a focus on neurodegenerative diseases and cancer","author":"Sayad","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb0055","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","article-title":"Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches","volume":"96","author":"Beermann","year":"2016","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/10409238.2013.844092","article-title":"Gene regulation by non-coding RNAs","volume":"49","author":"Patil","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1042\/BC20070137","article-title":"Small regulatory non-coding RNAs in bacteria: physiology and mechanistic aspects","volume":"101","author":"Repoila","year":"2009","journal-title":"Biol. Cell."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0070","doi-asserted-by":"crossref","DOI":"10.1515\/jib-2019-0027","article-title":"Non-coding RNAs and their integrated networks","volume":"16","author":"Zhang","year":"2019","journal-title":"J. Integrative Bioinformatics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s11658-022-00317-9","article-title":"MicroRNA let-7 and viral infections: focus on mechanisms of action","volume":"27","author":"Letafati","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0085","series-title":"Non-coding RNAs in colorectal cancer","first-page":"3","article-title":"Non-coding RNAs: classification, biology and functioning","author":"Hombach","year":"2016"},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0090","article-title":"DLX6-AS1: a long non-coding RNA with oncogenic features","volume":"10","author":"Ghafouri-Fard","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113294","article-title":"Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis","volume":"418","author":"Najafi","year":"2022","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0663-2","article-title":"CircRNA: functions and properties of a novel potential biomarker for cancer","volume":"16","author":"Meng","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.801842","article-title":"The role of circular RNAs in the carcinogenesis of bladder cancer","volume":"12","author":"Ghafouri-Fard","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0110","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7150\/thno.29678","article-title":"Circular RNAs in immune responses and immune diseases","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.781414","article-title":"The role and clinical potentials of circular RNAs in prostate cancer","volume":"11","author":"Taheri","year":"2021","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125863_bb0120","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110504","article-title":"MiR-211 plays a dual role in cancer development: from tumor suppressor to tumor enhancer","volume":"101","author":"Shirvani","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0130","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1093\/hmg\/ddi101","article-title":"Small regulatory RNAs in mammals","volume":"14","author":"Mattick","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"5740","key":"10.1016\/j.ijbiomac.2023.125863_bb0135","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1111444","article-title":"Ribo-gnome: the big world of small RNAs","volume":"309","author":"Zamore","year":"2005","journal-title":"Science."},{"issue":"24","key":"10.1016\/j.ijbiomac.2023.125863_bb0140","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1073\/pnas.0508889103","article-title":"microRNAs exhibit high frequency genomic alterations in human cancer","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"19","key":"10.1016\/j.ijbiomac.2023.125863_bb0145","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.4161\/cc.5.19.3340","article-title":"Epigenetic activation of tumor suppressor microRNAs in human cancer cells","volume":"5","author":"Saito","year":"2006","journal-title":"Cell Cycle"},{"issue":"19","key":"10.1016\/j.ijbiomac.2023.125863_bb0150","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.4161\/cc.5.19.3319","article-title":"MicroRNAs: a new insight into cancer genome","volume":"5","author":"Zhang","year":"2006","journal-title":"Cell Cycle"},{"issue":"17","key":"10.1016\/j.ijbiomac.2023.125863_bb0155","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125863_bb0160","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/genes12060856","article-title":"Subcellular localization of miRNAs and implications in cellular homeostasis","volume":"12","author":"Jie","year":"2021","journal-title":"Genes."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110525","article-title":"MicroRNA-206 in human cancer: mechanistic and clinical perspectives","volume":"101","author":"Bahari Khasraghi","year":"2023","journal-title":"Cell. Signal."},{"issue":"6956","key":"10.1016\/j.ijbiomac.2023.125863_bb0170","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature01957","article-title":"The nuclear RNase III Drosha initiates microRNA processing","volume":"425","author":"Lee","year":"2003","journal-title":"Nature."},{"issue":"7014","key":"10.1016\/j.ijbiomac.2023.125863_bb0175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0180","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125863_bb0185","first-page":"1","article-title":"Identifying microRNA targets in different gene regions","volume":"15","author":"Xu","year":"2014","journal-title":"BMC Bioinform."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"cell."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0195","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1152\/physrev.00006.2010","article-title":"MicroRNAs in development and disease","volume":"91","author":"Sayed","year":"2011","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: contributions of translational repression and mRNA decay","volume":"12","author":"Huntzinger","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0205","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nsmb.2931","article-title":"From guide to target: molecular insights into eukaryotic RNA-interference machinery","volume":"22","author":"Ipsaro","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"39","key":"10.1016\/j.ijbiomac.2023.125863_bb0210","doi-asserted-by":"crossref","first-page":"14879","DOI":"10.1073\/pnas.0803230105","article-title":"A search for conserved sequences in coding regions reveals that the let-7 microRNA targets dicer within its coding sequence","volume":"105","author":"Forman","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125863_bb0215","first-page":"7215","article-title":"Oncogenic role of microRNA-532-5p in human colorectal cancer via targeting of the 5\u2019UTR of RUNX3","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125863_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079467","article-title":"MicroRNA miR-324-3p induces promoter-mediated expression of RelA gene","volume":"8","author":"Dharap","year":"2013","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.ijbiomac.2023.125863_bb0225","doi-asserted-by":"crossref","first-page":"9740","DOI":"10.1073\/pnas.0403293101","article-title":"An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues","volume":"101","author":"Liu","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125863_bb0230","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00381-006-0173-9","article-title":"Genome-wide microRNA profiling in human fetal nervous tissues by oligonucleotide microarray","volume":"22","author":"Zhao","year":"2006","journal-title":"Childs Nerv. Syst."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb0235","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gnh040","article-title":"A high-throughput method to monitor the expression of microRNA precursors","volume":"32","author":"Schmittgen","year":"2004","journal-title":"Nucleic Acids Res."},{"issue":"20","key":"10.1016\/j.ijbiomac.2023.125863_bb0240","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gni178","article-title":"Real-time quantification of microRNAs by stem\u2013loop RT\u2013PCR","volume":"33","author":"Chen","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125863_bb0245","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1073\/pnas.0511155103","article-title":"The colorectal microRNAome","volume":"103","author":"Cummins","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0250","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nmeth717","article-title":"Microarray-based, high-throughput gene expression profiling of microRNAs","volume":"1","author":"Nelson","year":"2004","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12935-023-02868-z","article-title":"MicroRNA-122 in human cancers: from mechanistic to clinical perspectives","volume":"23","author":"Faramin Lashkarian","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb0260","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00268-008-9836-x","article-title":"MicroRNAs: control and loss of control in human physiology and disease","volume":"33","author":"Li","year":"2009","journal-title":"World J. Surg."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0265","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12031-021-01945-0","article-title":"MiR-574-5P, miR-1827, and miR-4429 as potential biomarkers for schizophrenia","volume":"72","author":"Davarinejad","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109945","article-title":"Progress toward molecular therapy for diabetes mellitus: a focus on targeting inflammatory factors","volume":"189","author":"Dehghan","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb0275","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","article-title":"Long noncoding RNAs in cancer pathways","volume":"29","author":"Schmitt","year":"2016","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125863_bb0280","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/carcin\/bgx026","article-title":"Small non-coding RNA and cancer","volume":"38","author":"Romano","year":"2017","journal-title":"Carcinogenesis."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0285","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.omtn.2019.02.005","article-title":"Circular RNAs in cancer","volume":"16","author":"Bach","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0290","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12935-015-0185-1","article-title":"MicroRNA (miRNA) in cancer","volume":"15","author":"Reddy","year":"2015","journal-title":"Cancer Cell Int."},{"issue":"R1","key":"10.1016\/j.ijbiomac.2023.125863_bb0295","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1093\/hmg\/ddm056","article-title":"miRNAs in cancer: approaches, aetiology, diagnostics and therapy","volume":"16","author":"Blenkiron","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"5757","key":"10.1016\/j.ijbiomac.2023.125863_bb0300","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1126\/science.311.5757.36d","article-title":"Clarifications on miRNA and cancer","volume":"311","author":"Ruvkun","year":"2006","journal-title":"Science."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153833","article-title":"The role of circular RNAs in pancreatic cancer: new players in tumorigenesis and potential biomarkers","volume":"232","author":"Sayad","year":"2022","journal-title":"Pathol. Res. Pract."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125863_bb0310","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4161\/rna.20481","article-title":"The hallmarks of cancer: a long non-coding RNA point of view","volume":"9","author":"Gutschner","year":"2012","journal-title":"RNA Biol."},{"issue":"46","key":"10.1016\/j.ijbiomac.2023.125863_bb0315","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1038\/sj.onc.1209911","article-title":"MicroRNAs and the hallmarks of cancer","volume":"25","author":"Dalmay","year":"2006","journal-title":"Oncogene."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0320","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ijbiomac.2022.03.103","article-title":"Circular RNAs as emerging players in cervical cancer tumorigenesis; a review to roles and biomarker potentials","volume":"206","author":"Najafi","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125863_bb0325","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrg2634","article-title":"Causes and consequences of microRNA dysregulation in cancer","volume":"10","author":"Croce","year":"2009","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125863_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051723","article-title":"Regulatory mechanism of microRNA expression in cancer","volume":"21","author":"Ali Syeda","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13148-018-0587-8","article-title":"The role and mechanisms of action of microRNAs in cancer drug resistance","volume":"11","author":"Si","year":"2019","journal-title":"Clin. Epigenetics"},{"issue":"22","key":"10.1016\/j.ijbiomac.2023.125863_bb0340","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1158\/0008-5472.CAN-13-1841","article-title":"miRNA dysregulation in breast cancer","volume":"73","author":"Mulrane","year":"2013","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125863_bb0345","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjc.6605901","article-title":"MicroRNA in lung cancer","volume":"103","author":"Lin","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"30","key":"10.1016\/j.ijbiomac.2023.125863_bb0350","doi-asserted-by":"crossref","first-page":"50240","DOI":"10.18632\/oncotarget.16933","article-title":"Micrornas in prostate cancer: an overview","volume":"8","author":"Vanacore","year":"2017","journal-title":"Oncotarget."},{"issue":"46","key":"10.1016\/j.ijbiomac.2023.125863_bb0355","doi-asserted-by":"crossref","first-page":"81572","DOI":"10.18632\/oncotarget.19197","article-title":"The role of miRNA and lncRNA in gastric cancer","volume":"8","author":"Hao","year":"2017","journal-title":"Oncotarget."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0360","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PPO.0b013e318258b78f","article-title":"The role of microRNAs in colorectal cancer","volume":"18","author":"Schetter","year":"2012","journal-title":"Cancer J."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125863_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9050463","article-title":"Role of microRNAs in human osteosarcoma: future perspectives","volume":"9","author":"Llobat","year":"2021","journal-title":"Biomedicines."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0370","first-page":"11","article-title":"MicroRNA signature in melanoma: biomarkers and therapeutic targets","author":"Ghafouri-Fard","year":"2021","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125863_bb0375","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/s41388-018-0534-3","article-title":"Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP","volume":"38","author":"Zhang","year":"2019","journal-title":"Oncogene."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125863_bb0380","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1158\/1541-7786.MCR-09-0400","article-title":"Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPAR\u03b3 in non\u2013small cell lung CancerSpry4 inhibits transformed cell growth in NSCLC","volume":"8","author":"Tennis","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0385","article-title":"Research progress of TXNIP as a tumor suppressor gene participating in the metabolic reprogramming and oxidative stress of cancer cells in various cancers","volume":"10","author":"Chen","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0390","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ncb2024","article-title":"miR-9, a MYC\/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis","volume":"12","author":"Ma","year":"2010","journal-title":"Nat. Cell Biol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125863_bb0395","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/gb-2008-9-8-r127","article-title":"The miR-17-5p microRNA is a key regulator of the G1\/S phase cell cycle transition","volume":"9","author":"Cloonan","year":"2008","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0400","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/hep.26662","article-title":"MicroRNA-494 within an oncogenic microRNA megacluster regulates G1\/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer","volume":"59","author":"Lim","year":"2014","journal-title":"Hepatology."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125863_bb0405","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/jcm4091713","article-title":"MicroRNA-224 induces G1\/S checkpoint release in liver cancer","volume":"4","author":"An","year":"2015","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0410","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hep.22919","article-title":"MicroRNA-195 suppresses tumorigenicity and regulates G1\/S transition of human hepatocellular carcinoma cells","volume":"50","author":"Xu","year":"2009","journal-title":"Hepatology."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125863_bb0415","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1093\/nar\/gkr1278","article-title":"MicroRNA-26a\/b and their host genes cooperate to inhibit the G1\/S transition by activating the pRb protein","volume":"40","author":"Zhu","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-11-195","article-title":"MicroRNA-503 inhibits the G1\/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma","volume":"11","author":"Xiao","year":"2013","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125863_bb0425","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00109-010-0716-0","article-title":"MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs","volume":"89","author":"Aigner","year":"2011","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0430","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00432-022-04328-z","article-title":"The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review","volume":"149","author":"Najafi","year":"2023","journal-title":"J. Cancer Res. Clin."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125863_bb0435","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1440-1681.2012.05700.x","article-title":"Apoptosis and micro RNA aberrations in cancer","volume":"39","author":"Li","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0440","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jcp.22066","article-title":"MicroRNAs as gatekeepers of apoptosis","volume":"223","author":"Subramanian","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125863_bb0445","doi-asserted-by":"crossref","first-page":"8474","DOI":"10.18632\/oncotarget.3523","article-title":"MicroRNAs in apoptosis, autophagy and necroptosis","volume":"6","author":"Su","year":"2015","journal-title":"Oncotarget."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125863_bb0450","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5732\/cjc.30.0371","article-title":"Apoptosis and the target genes of microRNA-21","volume":"30","author":"Buscaglia","year":"2011","journal-title":"Chin. J. Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0455","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","article-title":"Angiogenesis in cancer","volume":"2","author":"Nishida","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0460","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tips.2007.10.014","article-title":"Targeting microRNA expression to regulate angiogenesis","volume":"29","author":"Kuehbacher","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb0465","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.vph.2011.06.006","article-title":"MicroRNA regulation in angiogenesis","volume":"55","author":"Caporali","year":"2011","journal-title":"Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0470","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1172-8-7","article-title":"MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma","volume":"8","author":"Sarver","year":"2013","journal-title":"Orphan. J. Rare Dis."},{"issue":"22","key":"10.1016\/j.ijbiomac.2023.125863_bb0475","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.1093\/nar\/gkq718","article-title":"MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor \u03b21: a novel role of miR-382","volume":"38","author":"Kriegel","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0480","doi-asserted-by":"crossref","first-page":"4708516","DOI":"10.1155\/2017\/4708516","article-title":"miR-382 contributes to renal tubulointerstitial fibrosis by downregulating HSPD1","volume":"2017","author":"Fang","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125863_bb0485","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41419-020-02876-1","article-title":"Upregulation of miR-382 contributes to renal fibrosis secondary to aristolochic acid-induced kidney injury via PTEN signaling pathway","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb0490","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physiolgenomics.00173.2011","article-title":"MiR-382 targeting of kallikrein 5 contributes to renal inner medullary interstitial fibrosis","volume":"44","author":"Kriegel","year":"2012","journal-title":"Physiol. Genomics"},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125863_bb0495","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.ajpath.2020.06.011","article-title":"The common miRNA signatures associated with mitochondrial dysfunction in different muscular dystrophies","volume":"190","author":"Aksu-Menges","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0500","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020405","article-title":"Regulatory role of microRNAs in muscle atrophy during exercise intervention","volume":"19","author":"Zhang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125863_bb0505","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.4103\/1673-5374.189195","article-title":"miRNA targeted signaling pathway in the early stage of denervated fast and slow muscle atrophy","volume":"11","author":"Li","year":"2016","journal-title":"Neural Regen. Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125863_bb0510","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.celrep.2015.07.066","article-title":"TNF-\u03b1-induced microRNAs control dystrophin expression in Becker muscular dystrophy","volume":"12","author":"Fiorillo","year":"2015","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125863_bb0515","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4161\/epi.5.7.13055","article-title":"Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome","volume":"5","author":"Urdinguio","year":"2010","journal-title":"Epigenetics."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125863_bb0520","first-page":"3663","article-title":"Study on the role of Hsa-miR-382-5p in epidural fibrosis","volume":"22","author":"Lin","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125863_bb0525","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.21037\/jtd-20-2066","article-title":"Identification of microRNAs enriched in exosomes in human pericardial fluid of patients with atrial fibrillation based on bioinformatic analysis","volume":"12","author":"Liu","year":"2020","journal-title":"J. Thoracic Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042202","article-title":"Overexpression of miR-1306-5p, miR-3195, and miR-3914 inhibits Ameloblast differentiation through suppression of genes associated with human amelogenesis imperfecta","volume":"22","author":"Yoshioka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125863_bb0535","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/1878-0261.12387","article-title":"Role of TGF-\u03b21\/miR-382-5p\/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis","volume":"12","author":"Rossi","year":"2018","journal-title":"Mol. Oncol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125863_bb0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051387","article-title":"Cocaine enhances HIV-1 replication in CD4+ T cells by down-regulating MiR-125b","volume":"7","author":"Mantri","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125863_bb0545","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/jbmr.2897","article-title":"Serum miRNA signatures are indicative of skeletal fractures in postmenopausal women with and without type 2 diabetes and influence osteogenic and adipogenic differentiation of adipose tissue-derived mesenchymal stem cells in vitro","volume":"31","author":"Heilmeier","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"19","key":"10.1016\/j.ijbiomac.2023.125863_bb0550","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1089\/scd.2016.0150","article-title":"miR-382-5p controls hematopoietic stem cell differentiation through the downregulation of MXD1","volume":"25","author":"Zini","year":"2016","journal-title":"Stem Cells Dev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125863_bb0555","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1159\/000492654","article-title":"Mir-382 promotes differentiation of rat liver progenitor cell WB-F344 by targeting Ezh2","volume":"48","author":"Zheng","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0560","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s12035-015-9106-5","article-title":"Serum MicroRNA signatures in migraineurs during attacks and in pain-free periods","volume":"53","author":"Andersen","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0565","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.biopha.2016.12.007","article-title":"miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer","volume":"86","author":"Chen","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb0570","first-page":"2417","article-title":"MicroRNA-382 inhibits cancer cell growth and metastasis in NSCLC via targeting LMO3","volume":"17","author":"Chen","year":"2019","journal-title":"Exp Ther. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0575","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3892\/etm.2022.11367","article-title":"miR-382-3p downregulation contributes to the carcinogenesis of lung adenocarcinoma by promoting AKT SUMOylation and phosphorylation","volume":"24","author":"Fang","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0580","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13148-016-0268-4","article-title":"The emerging role of lysine methyltransferase SETD8 in human diseases","volume":"8","author":"Milite","year":"2016","journal-title":"Clin. Epigenetics"},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125863_bb0585","first-page":"2755","article-title":"LMO3 promotes gastric cancer cell invasion and proliferation through Akt-mTOR and Akt-GSK3\u03b2 signaling","volume":"41","author":"Qiu","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0903-3","article-title":"LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling","volume":"37","author":"Cheng","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125863_bb0595","first-page":"1271","article-title":"miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer","volume":"7","author":"Song","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0600","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ijbiomac.2022.11.166","article-title":"Recent insights into the roles of circular RNAs in human brain development and neurologic diseases","volume":"225","author":"Najafi","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0605","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.2147\/CMAR.S250893","article-title":"Long non-coding RNA SNHG14 regulates SPIN1 expression to accelerate tumor progression in non-small cell lung cancer by sponging miR-382-5p","volume":"12","author":"Chen","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0610","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12890-021-01617-0","article-title":"Circular RNA NEK6 contributes to the development of non-small-cell lung cancer by competitively binding with miR-382-5p to elevate BCAS2 expression at post-transcriptional level","volume":"21","author":"Cao","year":"2021","journal-title":"BMC Pulm Med."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144099","article-title":"Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377\/382\/498","volume":"720","author":"Wang","year":"2019","journal-title":"Gene."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0620","doi-asserted-by":"crossref","first-page":"21014","DOI":"10.1038\/s41598-021-99555-8","article-title":"DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p\/miR-382-5p\/CELF1 axis","volume":"11","author":"Zhao","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb0625","first-page":"469","article-title":"Reduced circulating exosomal miR-382 predicts unfavorable outcome in non-small cell lung cancer","volume":"14","author":"Luo","year":"2021","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125863_bb0630","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/cas.13697","article-title":"Exosomes in cancer development and clinical applications","volume":"109","author":"Tai","year":"2018","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0635","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13578-022-00808-4","article-title":"Recent highlights in the immunomodulatory aspects of Treg cell-derived extracellular vesicles: special emphasis on autoimmune diseases and transplantation","volume":"12","author":"Asemani","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0640","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.semcancer.2017.02.006","article-title":"The role of exosomes in cancer metastasis","volume":"44","author":"Steinbichler","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0645","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-023-01370-3","article-title":"Extracellular vesicle\u2013based drug delivery in cancer immunotherapy","author":"Najafi","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0650","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5114\/pg.2018.81072","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Gastroenterol. Rev. Przegl\u0105d Gastroenterol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125863_bb0655","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0660","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1476-4598-8-102","article-title":"MicroRNAs in colorectal cancer: translation of molecular biology into clinical application","volume":"8","author":"Slaby","year":"2009","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0665","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40659-018-0200-9","article-title":"MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1","volume":"51","author":"Ren","year":"2018","journal-title":"Biol. Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125863_bb0670","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/mc.22466","article-title":"MiR-382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer","volume":"55","author":"Zhou","year":"2016","journal-title":"Mol. Carcinog."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125863_bb0675","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180441","article-title":"MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer","volume":"39","author":"Yao","year":"2019","journal-title":"Biosci. Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125863_bb0680","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4149\/neo_2022_220111N42","article-title":"lncRNA PSMB8-AS1 promotes colorectal cancer progression through sponging miR-1299 to upregulate ADAMTS5","volume":"69","author":"Zhao","year":"2022","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0685","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1080\/21655979.2021.1889130","article-title":"Circular RNA circ_0000467 regulates colorectal cancer development via miR-382-5p\/EN2 axis","volume":"12","author":"Xie","year":"2021","journal-title":"Bioengineered."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0690","first-page":"83","article-title":"Polydatin exerts an antitumor effect through regulating the miR-382\/PD-L1 axis in colorectal cancer","volume":"35","author":"Jin","year":"2020","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112213","article-title":"A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: toward single-cell sequencing-guided biocompatible-based delivery","volume":"143","author":"Shadbad","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/genes12020176","article-title":"Predictive value of circulating miRNAs in lymph node metastasis for colon cancer","volume":"12","author":"Lee","year":"2021","journal-title":"Genes (Basel)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0705","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bbrc.2020.03.165","article-title":"Circular RNA hsa_circ_0008285 inhibits colorectal cancer cell proliferation and migration via the miR-382-5p\/PTEN axis","volume":"527","author":"Wang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0710","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0715","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/JHC.S61146","article-title":"Hepatocellular carcinoma: a review","volume":"3","author":"Balogh","year":"2016","journal-title":"J. Hepatocell Carcinoma."},{"issue":"1732","key":"10.1016\/j.ijbiomac.2023.125863_bb0720","doi-asserted-by":"crossref","first-page":"20160274","DOI":"10.1098\/rstb.2016.0274","article-title":"Viral hepatitis and liver cancer","volume":"372","author":"Ringehan","year":"2017","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125863_bb0725","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbagrm.2011.07.010","article-title":"MicroRNA in HCV infection and liver cancer","volume":"1809","author":"Kumar","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) Gene Regul. Mechan."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0730","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jhep.2017.04.009","article-title":"Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets","volume":"67","author":"Klingenberg","year":"2017","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0735","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bjc.6606010","article-title":"The role of microRNAs in liver cancer progression","volume":"104","author":"Huang","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0740","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrgastro.2017.169","article-title":"Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications","volume":"15","author":"Wong","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0745","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12957-022-02638-7","article-title":"miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K\/Akt signaling pathway","volume":"20","author":"Lv","year":"2022","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0750","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.2147\/CMAR.S324072","article-title":"miRNA-382-5p suppresses the expression of farnesoid X receptor to promote progression of liver cancer","volume":"13","author":"Nie","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109621","article-title":"Circ_0001178 regulates miR-382\/VEGFA axis to facilitate hepatocellular carcinoma progression","volume":"72","author":"Gao","year":"2020","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbamcr.2017.09.020","article-title":"Hepatitis B core protein promotes liver cancer metastasis through miR-382-5p\/DLC-1 axis","volume":"1865","author":"Du","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125863_bb0765","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/15384047.2020.1840886","article-title":"CYP2C8 regulated by GAS5\/miR-382-3p exerts anti-cancerous properties in liver cancer","volume":"21","author":"Li","year":"2020","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0770","first-page":"120","article-title":"MiR-382 targets GOLM1 to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival","volume":"8","author":"Zhang","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0775","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.omto.2020.07.012","article-title":"Overexpression of miR-382 sensitizes hepatocellular carcinoma cells to \u03b3\u03b4 T cells by inhibiting the expression of c-FLIP","volume":"18","author":"Chen","year":"2020","journal-title":"Mol. Ther. Oncolytics."},{"issue":"14","key":"10.1016\/j.ijbiomac.2023.125863_bb0780","doi-asserted-by":"crossref","first-page":"22443","DOI":"10.18632\/oncotarget.12338","article-title":"MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG\/Ras\/ERK signaling axis","volume":"8","author":"Ho","year":"2017","journal-title":"Oncotarget."},{"issue":"45","key":"10.1016\/j.ijbiomac.2023.125863_bb0785","doi-asserted-by":"crossref","first-page":"42259","DOI":"10.1074\/jbc.M105888200","article-title":"RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer","volume":"276","author":"Finlin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0790","article-title":"Lidocaine promoted ferroptosis by targeting miR-382-5p \/SLC7A11 axis in ovarian and breast cancer","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0795","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.2147\/CMAR.S198624","article-title":"SNHG1 contributes to proliferation and invasion by regulating miR-382 in breast cancer","volume":"11","author":"Zheng","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0800","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3892\/ol.2016.4582","article-title":"Serum expression levels of microRNA-382-3p, -598-3p, -1246 and -184 in breast cancer patients","volume":"12","author":"Fu","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0805","doi-asserted-by":"crossref","first-page":"6852917","DOI":"10.1155\/2019\/6852917","article-title":"Presence of circulating miR-145, miR-155, and miR-382 in exosomes isolated from serum of breast cancer patients and healthy donors","volume":"2019","author":"Gonzalez-Villasana","year":"2019","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb0810","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s13277-013-0940-7","article-title":"MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects","volume":"34","author":"Miao","year":"2013","journal-title":"Tumor Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0815","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2741\/4142","article-title":"The miRNAs in the pathgenesis of osteosarcoma","volume":"18","author":"Liang","year":"2013","journal-title":"Front. Biosci. (Landmark Ed)."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0820","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/359739","article-title":"MicroRNA involvement in osteosarcoma","volume":"2012","author":"Kobayashi","year":"2012","journal-title":"Sarcoma."},{"issue":"19","key":"10.1016\/j.ijbiomac.2023.125863_bb0825","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.18632\/oncotarget.2418","article-title":"miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma","volume":"5","author":"Xu","year":"2014","journal-title":"Oncotarget."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0830","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/mt.2014.197","article-title":"miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1","volume":"23","author":"Xu","year":"2015","journal-title":"Mol. Ther."},{"issue":"20","key":"10.1016\/j.ijbiomac.2023.125863_bb0835","first-page":"20212","article-title":"LINC00265 targets miR-382-5p to regulate SAT1, VAV3 and angiogenesis in osteosarcoma","volume":"12","author":"Xiao","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0840","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cbf.3452","article-title":"Circ_0001658 promotes the proliferation and metastasis of osteosarcoma cells via regulating miR-382-5p\/YB-1 axis","volume":"38","author":"Wang","year":"2020","journal-title":"Cell Biochem. Funct."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0845","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s13577-020-00335-9","article-title":"Circular RNA hsa_circ_0002052 promotes osteosarcoma via modulating miR-382\/STX6 axis","volume":"33","author":"Zhang","year":"2020","journal-title":"Hum. Cell"},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113906","article-title":"Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy","volume":"156","author":"Rouzbahani","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0855","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.2147\/OTT.S196322","article-title":"The role of miR-382-5p in glioma cell proliferation, migration and invasion","volume":"12","author":"Wang","year":"2019","journal-title":"Onco Targets Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0860","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.prp.2018.01.004","article-title":"Downregulation of SETD8 by miR-382 is involved in glioma progression","volume":"214","author":"Ma","year":"2018","journal-title":"Pathol. Res. Pract."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125863_bb0865","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/cam4.3759","article-title":"Circ-UBAP2 functions as sponges of miR-1205 and miR-382 to promote glioma progression by modulating STC1 expression","volume":"10","author":"Wang","year":"2021","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0870","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13046-018-0990-1","article-title":"MOV10 binding circ-DICER1 regulates the angiogenesis of glioma via miR-103a-3p\/miR-382-5p mediated ZIC4 expression change","volume":"38","author":"He","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0875","doi-asserted-by":"crossref","first-page":"G309","DOI":"10.1152\/ajpgi.00322.2019","article-title":"microRNA-382 suppresses the progression of pancreatic cancer through the PI3K\/Akt signaling pathway by inhibition of Anxa3","volume":"319","author":"Wan","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125863_bb0880","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1159\/000479990","article-title":"The Lncrna-TUG1\/EZH2 Axis promotes pancreatic cancer cell proliferation, migration and EMT phenotype formation through sponging Mir-382","volume":"42","author":"Zhao","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb0885","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13046-020-01687-8","article-title":"LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p\/STAT1\/PD-L1 axis","volume":"39","author":"Zhang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125863_bb0890","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.3892\/or.2016.5141","article-title":"MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"issue":"23","key":"10.1016\/j.ijbiomac.2023.125863_bb0895","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.3748\/wjg.v23.i23.4243","article-title":"miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma","volume":"23","author":"Feng","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125863_bb0900","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.3892\/mmr.2017.7396","article-title":"MicroRNA-382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNF-mediated PI3K\/AKT signalling pathway","volume":"16","author":"Song","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125863_bb0905","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23258","article-title":"CircAP2A2 acts as a ceRNA to participate in infantile hemangiomas progression by sponging miR-382-5p via regulating the expression of VEGFA","volume":"34","author":"Yuan","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0910","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3892\/ijmm.2017.2863","article-title":"Downregulation of miR-382 by propranolol inhibits the progression of infantile hemangioma via the PTEN-mediated AKT\/mTOR pathway","volume":"39","author":"Li","year":"2017","journal-title":"Int. J. Mol. Med."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125863_bb0915","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223608","article-title":"Clinical significance and prognostic role of hypoxia-induced microRNA 382 in gastric adenocarcinoma","volume":"14","author":"Seo","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0920","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drup.2011.03.001","article-title":"Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways","volume":"14","author":"Rohwer","year":"2011","journal-title":"Drug Resist. Updat."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb0925","article-title":"Hypoxia-induced chemoresistance in cancer cells: the role of not only HIF-1","volume":"159","author":"Doktorova","year":"2015","journal-title":"Biomed. Papers Med Faculty Palacky Univ. Olomouc."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125863_bb0930","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.1093\/nar\/gku515","article-title":"MicroRNA-382 induced by HIF-1\u03b1 is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog","volume":"42","author":"Seok","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2018.11.012","article-title":"miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN","volume":"54","author":"Liu","year":"2019","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb0940","first-page":"1319","article-title":"Cancer-associated fibroblast-derived exosomal miR-382-5p promotes the migration and invasion of oral squamous cell carcinoma","volume":"42","author":"Sun","year":"2019","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125863_bb0945","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.2016.2240","article-title":"Biomarkers and surrogate endpoints: developing common terminology and definitions","volume":"315","author":"Robb","year":"2016","journal-title":"JAMA."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0950","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med."},{"issue":"7187","key":"10.1016\/j.ijbiomac.2023.125863_bb0955","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature06913","article-title":"The cancer biomarker problem","volume":"452","author":"Sawyers","year":"2008","journal-title":"Nature."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125863_bb0960","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/ijc.30546","article-title":"Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets","volume":"140","author":"Chandra Gupta","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0965","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41416-021-01672-8","article-title":"Non-coding RNAs as liquid biopsy biomarkers in cancer","volume":"126","author":"Toden","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"22","key":"10.1016\/j.ijbiomac.2023.125863_bb0970","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.3748\/wjg.v21.i22.6884","article-title":"Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma","volume":"21","author":"Qi","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0975","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/259454","article-title":"Serum circulating microRNA profiling for identification of potential breast cancer biomarkers","volume":"34","author":"Mar-Aguilar","year":"2013","journal-title":"Dis. Markers"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125863_bb0980","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.juro.2009.01.110","article-title":"A duplex quantitative polymerase chain reaction assay based on quantification of <i>&#x3b1;-methylacyl-CoA racemase<\/i> transcripts and <i>prostate cancer antigen 3<\/i> in urine sediments improved diagnostic accuracy for prostate cancer","volume":"181","author":"Ouyang","year":"2009","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125863_bb0985","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","article-title":"APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer","volume":"52","author":"Groskopf","year":"2006","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125863_bb0990","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/PPO.0b013e318258b5d6","article-title":"The therapeutic potential of microRNAs in cancer","volume":"18","author":"Thorsen","year":"2012","journal-title":"Cancer J."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb0995","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.biocel.2014.05.040","article-title":"microRNA-7: a tumor suppressor miRNA with therapeutic potential","volume":"54","author":"Kalinowski","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125863_bb1000","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s40291-018-0316-1","article-title":"Oncogenic and tumor-suppressive roles of microRNAs with special reference to apoptosis: molecular mechanisms and therapeutic potential","volume":"22","author":"Kashyap","year":"2018","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112743","article-title":"Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections","volume":"148","author":"Najafi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb1010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2019.01.017","article-title":"CRISPR-Cas9 for cancer therapy: opportunities and challenges","volume":"447","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125863_bb1015","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nchembio.1551","article-title":"DrugTargetSeqR: a genomics- and CRISPR-Cas9\u2013based method to analyze drug targets","volume":"10","author":"Kasap","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb1020","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","article-title":"One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering","volume":"153","author":"Wang","year":"2013","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb1025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/biomedicines6040105","article-title":"CRISPR\/Cas9 for cancer therapy: hopes and challenges","volume":"6","author":"Martinez-Lage","year":"2018","journal-title":"Biomedicines."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125863_bb1030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1618","article-title":"Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model","volume":"28","author":"Ma","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2023.125863_bb1035","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1158\/0008-5472.CAN-16-1571","article-title":"Ablation of miR-10b suppresses oncogene-induced mammary tumorigenesis and metastasis and reactivates tumor-suppressive PathwaysGenetic dissection of miR-10b and breast cancer","volume":"76","author":"Kim","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb1040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2015.08.011","article-title":"Small molecules targeting microRNA for cancer therapy: promises and obstacles","volume":"219","author":"Wen","year":"2015","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125863_bb1045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/ijms19010065","article-title":"Development of novel therapeutic agents by inhibition of oncogenic microRNAs","volume":"19","author":"Nguyen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb1050","first-page":"10","article-title":"CRISPR gene therapy: applications, limitations, and implications for the future","author":"Uddin","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2023.125863_bb1055","first-page":"8","article-title":"CRISPR\/Cas: advances, limitations, and applications for precision cancer research","author":"Yang","year":"2021","journal-title":"Front. Med."}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2023.125863","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000}},{"DOI":"10.1016\/j.ijbiomac.2026.153957","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023027587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023027587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:17:31Z","timestamp":1785791851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023027587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":211,"alternative-id":["S0141813023027587"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125863","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"125863"}}